Magnetic/Acoustic Dual‐Controlled Microrobot Overcoming Oto‐Biological Barrier for On‐Demand Multidrug Delivery against Hearing Loss

• Published in: Small (Weinheim an der Bergstrasse, Germany) p. e2401369
• Main Authors: Yi, Xinyang, Guo, Lifang, Zeng, Qi, Huang, Suling, Wen, Dingsheng, Wang, Chu, Kou, Yuwei, Zhang, Ming, Li, Huaan, Wen, Lu, Chen, Gang
• Format: Journal Article
• Language: English
• Published: 17.07.2024
• ISSN: 1613-6810; 1613-6829; 1613-6829
• DOI: 10.1002/smll.202401369

Abstract Multidrug combination therapy in the inner ear faces diverse challenges due to the distinct physicochemical properties of drugs and the difficulties of overcoming the oto‐biologic barrier. Although nanomedicine platforms offer potential solutions to multidrug delivery, the access of drugs to the inner ear remains limited. Micro/nanomachines, capable of delivering cargo actively, are promising tools for overcoming bio‐barriers. Herein, a novel microrobot‐based strategy to penetrate the round window membrane (RWM) is presented and multidrug in on‐demand manner is delivered. The tube‐type microrobot (TTMR) is constructed using the template‐assisted layer‐by‐layer (LbL) assembly of chitosan/ferroferric oxide/silicon dioxide (CS/Fe 3 O 4 /SiO 2 ) and loaded with anti‐ototoxic drugs (curcumin, CUR and tanshinone IIA, TSA) and perfluorohexane (PFH). Fe 3 O 4 provides magnetic actuation, while PFH ensures acoustic propulsion. Upon ultrasound stimulation, the vaporization of PFH enables a microshotgun‐like behavior, propelling the drugs through barriers and driving them into the inner ear. Notably, the proportion of drugs entering the inner ear can be precisely controlled by varying the feeding ratios. Furthermore, in vivo studies demonstrate that the drug‐loaded microrobot exhibits superior protective effects and excellent biosafety toward cisplatin (CDDP)‐induced hearing loss. Overall, the microrobot‐based strategy provides a promising direction for on‐demand multidrug delivery for ear diseases.